- Home
- NRXP vs MAXN Comparison
NRXP vs MAXN Comparison
Compare NRXP & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- MAXN
- Stock Information
- Founded
- NRXP 2015
- MAXN 2019
- Country
- NRXP United States
- MAXN Singapore
- Employees
- NRXP N/A
- MAXN N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- MAXN Semiconductors
- Sector
- NRXP Health Care
- MAXN Technology
- Exchange
- NRXP Nasdaq
- MAXN Nasdaq
- Market Cap
- NRXP 58.5M
- MAXN 56.0M
- IPO Year
- NRXP N/A
- MAXN N/A
- Fundamental
- Price
- NRXP $2.89
- MAXN $3.99
- Analyst Decision
- NRXP Strong Buy
- MAXN Sell
- Analyst Count
- NRXP 4
- MAXN 1
- Target Price
- NRXP $28.50
- MAXN $4.00
- AVG Volume (30 Days)
- NRXP 283.3K
- MAXN 174.4K
- Earning Date
- NRXP 08-19-2025
- MAXN 09-02-2025
- Dividend Yield
- NRXP N/A
- MAXN N/A
- EPS Growth
- NRXP N/A
- MAXN N/A
- EPS
- NRXP N/A
- MAXN N/A
- Revenue
- NRXP N/A
- MAXN $176,414,000.00
- Revenue This Year
- NRXP N/A
- MAXN $100.37
- Revenue Next Year
- NRXP $230.95
- MAXN $24.61
- P/E Ratio
- NRXP N/A
- MAXN N/A
- Revenue Growth
- NRXP N/A
- MAXN N/A
- 52 Week Low
- NRXP $1.10
- MAXN $2.49
- 52 Week High
- NRXP $6.01
- MAXN $23.11
- Technical
- Relative Strength Index (RSI)
- NRXP 54.48
- MAXN 51.46
- Support Level
- NRXP $2.30
- MAXN $3.50
- Resistance Level
- NRXP $2.68
- MAXN $4.28
- Average True Range (ATR)
- NRXP 0.19
- MAXN 0.41
- MACD
- NRXP 0.02
- MAXN -0.07
- Stochastic Oscillator
- NRXP 89.39
- MAXN 33.33
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.